Mirae Asset Global ETFs Holdings’s Neumora Therapeutics NMRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.3K	Buy	+47,251	New	+$90K	﹤0.01%	2916
2025 Q2	–	Sell	-50,007	Closed	-$50K	–	3161
2025 Q1	$50K	Buy	50,007 +2,137	+4%	+$3.66K	﹤0.01%	2848
2024 Q4	$507K	Buy	47,870 +1,667	+4%	+$20K	﹤0.01%	1910
2024 Q3	$610K	Buy	46,203 +38,068	+468%	+$444K	﹤0.01%	1817
2024 Q2	$80K	Buy	+8,135	New	+$84.2K	﹤0.01%	2652

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NMRA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 47,251 shares worth $80.3K. The stake represents ﹤0.01% of the portfolio and ranks #2916 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in NMRA as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in NMRA in Q2 2024 and has held it in 5 quarters since. The position peaked at $610K in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 47,251 shares of Neumora Therapeutics worth $80.3K as of Q2 2026.
Neumora Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Neumora Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2916 holding.
Mirae Asset Global ETFs Holdings first reported a position in Neumora Therapeutics in Q2 2024 and has held it in 5 quarters since.
Mirae Asset Global ETFs Holdings's Neumora Therapeutics position peaked at $610K in Q3 2024.
113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.